FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Claudio Borghi

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Claudio Borghi; Arrigo F G Cicero; Daniela D Esposti; Stefano Omboni; Dragos Vinereanu; Giuseppe Ambrosio; Ettore Ambrosioni; Stefano Bacchelli; Dario Zava
Zofenopril and ramipril and acetylsalicylic acid in postmyocardial infarction patients with left ventricular systolic dysfunction: a retrospective analysis in hypertensive patients of the SMILE-4 study.
Arrigo F G Cicero; Claudio Borghi
Evidence of clinically relevant efficacy for dietary supplements and nutraceuticals.
Arrigo F G Cicero; Giuseppe Derosa; Elisa Grandi; Pamela Maffioli; Alessandra Reggi; Claudio Borghi
Influence of metabolic syndrome superposition on familial combined hyperlipoproteinemia cardiovascular complication rate.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Claudio Borghi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Claudio Borghi; Arrigo F G Cicero; Daniela D Esposti; Stefano Omboni; Dragos Vinereanu; Giuseppe Ambrosio; Ettore Ambrosioni; Stefano Bacchelli; Dario Zava
Zofenopril and ramipril and acetylsalicylic acid in postmyocardial infarction patients with left ventricular systolic dysfunction: a retrospective analysis in hypertensive patients of the SMILE-4 study.
Journal of hypertension 2013;31(6):1256-64.
2013: Arrigo F G Cicero; Claudio Borghi
Evidence of clinically relevant efficacy for dietary supplements and nutraceuticals.
Current hypertension reports 2013;15(3):260-7.
2013: Arrigo F G Cicero; Giuseppe Derosa; Elisa Grandi; Pamela Maffioli; Alessandra Reggi; Claudio Borghi
Influence of metabolic syndrome superposition on familial combined hyperlipoproteinemia cardiovascular complication rate.
Archives of medical science : AMS 2013;9(2):238-42.
2013: Claudio Borghi
Uric acid as a cross-over between rheumatology and cardiovascular disease.
Current medical research and opinion 2013;29 Suppl 3():1-2.
2013: Arrigo F G Cicero; Sergio D'Addato; Alessandra Reggi; Giulio Marchesini Reggiani; Claudio Borghi
Hepatic steatosis index and lipid accumulation product as middle-term predictors of incident metabolic syndrome in a large population sample: data from the Brisighella Heart Study.
Internal and emergency medicine 2013;8(3):265-7.
2013: Alessandro Spighi; Elisa Tartagni; Sergio D'Addato; Ada Dormi; Claudio Borghi
Lipid-lowering treatment in patients at high cardiovascular risk discharged from an Italian hospital.
Journal of cardiovascular medicine (Hagerstown, Md.) 2013;14(4):270-5.
2013: Arrigo F G Cicero; Francois Aubin; Veronique Azais-Braesco; Claudio Borghi
Do the lactotripeptides isoleucine-proline-proline and valine-proline-proline reduce systolic blood pressure in European subjects? A meta-analysis of randomized controlled trials.
American journal of hypertension 2013;26(3):442-9.
2013: Arrigo F G Cicero; Sergio D'Addato; Elisa Grandi; Alessandra Reggi; Elisa Tartagni; Claudio Borghi
Dietary determinants of oxidized-low-density lipoprotein antibodies in a sample of pharmacologically untreated non-smoker subjects: data from the Brisighella heart study.
Advances in clinical and experimental medicine : official organ Wroclaw Medical University 2013;22(1):69-76.
2012: Claudio Borghi; Ilenia Pareo
Omega-3 in antiarrhythmic therapy : cons position.
High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension 2012;19(4):207-11.
2012: Arrigo F G Cicero; Angelo Parini; Alessandra Reggi; Claudio Borghi
Application of polyunsaturated fatty acids in internal medicine: beyond the established cardiovascular effects.
Archives of medical science : AMS 2012;8(5):784-93.
2012: Claudio Borghi
Hypertension: quo vadis?
Current vascular pharmacology 2012;10(6):739-42.
2012: Claudio Borghi; Arrigo F G Cicero
Hypertension: management perspectives.
Expert opinion on pharmacotherapy 2012;13(14):1999-2003.
2012: Claudio Borghi; Antonio Pirodda
Omega-3 fatty acids: a promising possible treatment for Meniere's Disease and other inner ear disorders of unknown origin?
Medical hypotheses 2012;79(4):468-70.
2012: Claudio Borghi; Elisa Tartagni
The older patient with hypertension: care and cure.
Therapeutic advances in chronic disease 2012;3(5):231-6.
2012: Arrigo F G Cicero; Sergio D'Addato; Alienor Ferroni; Francesca Santi; Claudio Borghi
Leisure-time physical activity and cardiovascular disease mortality: the Brisighella Heart Study.
Journal of cardiovascular medicine (Hagerstown, Md.) 2012;13(9):559-64.
2012: Antonio Pirodda; Arrigo Francesco Giuseppe Cicero; Claudio Borghi
Kidney disease and inner ear impairment: a simpler and closer pathogenic analogy?
Internal and emergency medicine 2012;7 Suppl 2():S93-5.
2012: Claudio Borghi; Stefano Bacchelli; Daniela Degli Esposti
Long-term clinical experience with zofenopril.
Expert review of cardiovascular therapy 2012;10(8):973-82.
2012: Claudio Borghi; Arrigo F G Cicero
The role of irbesartan in the treatment of patients with hypertension: a comprehensive and practical review.
High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension 2012;19(1):19-31.
2012: Arrigo F G Cicero; Sergio D'Addato; Ada Dormi; Martina Rosticci; Francesca Santi; Maddalena Veronesi; Claudio Borghi
Relationship between blood pressure, cholesterolemia and serum apolipoprotein B in a large population sample: the Brisighella Heart Study.
Journal of hypertension 2012;30(3):492-6.
2012: Claudio Borghi; Francesca Santi
Fixed combination of lercanidipine and enalapril in the management of hypertension: focus on patient preference and adherence.
Patient preference and adherence 2012;6():449-55.
2012: Arrigo F G Cicero; Paolo Magni; Massimo Moré; Massimiliano Ruscica; Felice Strollo; Claudio Borghi
Metabolic syndrome, adipokines and hormonal factors in pharmacologically untreated adult elderly subjects from the Brisighella Heart Study historical cohort.
Obesity facts 2012;5(3):319-26.
2012: A F G Cicero; A Ferroni; M Rosticci; E Strocchi; Maddalena Veronesi; Stefano Bacchelli; Claudio Borghi
Predictors of the short-term effect of isoleucine-proline-proline/valine-proline-proline lactotripeptides from casein on office and ambulatory blood pressure in subjects with pharmacologically untreated high-normal blood pressure or first-degree hypertension.
Clinical and experimental hypertension (New York, N.Y. : 1993) 2012;34(8):601-5.
2012: Arrigo F G Cicero; Beatrice Gerocarni; Martina Rosticci; Claudio Borghi
Blood pressure and metabolic effect of a combination of lercanidipine with different antihypertensive drugs in clinical practice.
Clinical and experimental hypertension (New York, N.Y. : 1993) 2012;34(2):113-7.
2011: Arrigo F G Cicero; Beatrice Gerocarni; Martina Rosticci; Enrico Strocchi; Maddalena Veronesi; Stefano Bacchelli; Claudio Borghi
Lactotripeptides effect on office and 24-h ambulatory blood pressure, blood pressure stress response, pulse wave velocity and cardiac output in patients with high-normal blood pressure or first-degree hypertension: a randomized double-blind clinical trial.
Hypertension research : official journal of the Japanese Society of Hypertension 2011;34(9):1035-40.
2011: Claudio Borghi; Arrigo Francesco Giuseppe Cicero; Daniela Degli Esposti; Vincenzo Immordino; Stefano Bacchelli; Nicola Rizzo; Francesca Santi; Ettore Ambrosioni
Hemodynamic and neurohumoral profile in patients with different types of hypertension in pregnancy.
Internal and emergency medicine 2011;6(3):227-34.
2011: Arrigo F G Cicero; Elena Dozio; Paolo Magni; Massimo Moré; Massimiliano Ruscica; Liliana Steffani; Claudio Borghi; Felice Strollo
Adipokines and sexual hormones associated with the components of the metabolic syndrome in pharmacologically untreated subjects: data from the brisighella heart study.
International journal of endocrinology 2011;2011():724816.
2011: Claudio Borghi; Cristina Brandolini; Arrigo Fg Cicero; Eugenio Cosentino; Ada Dormi; Maria C Rimondi; Elisa R Rinaldi; Maddalena Veronesi; Antonio Pirodda
Tinnitus in elderly patients and prognosis of mild-to-moderate congestive heart failure: a cross-sectional study with a long-term extension of the clinical follow-up.
BMC medicine 2011;9():80.
2010: Arrigo F G Cicero; Martina Rosticci; Maddalena Veronesi; Stefano Bacchelli; Enrico Strocchi; Camilla Melegari; Elisa Grandi; Claudio Borghi
Hemodynamic effects of lactotripeptides from casein hydrolysate in Mediterranean normotensive subjects and patients with high-normal blood pressure: a randomized, double-blind, crossover clinical trial.
Journal of medicinal food 2010;13(6):1363-8.
2010: Nicolino C F Rossi; Ornella Montebarocci; Paola Surcinelli; Bruno Baldaro; Vincenzo Immordino; Claudio Borghi
Greater pressor reactivity in women with pre-eclampsia is not related to specific psychological or emotional stressors.
Psychological reports 2010;107(2):415-23.
2010: Maria Grazia Prandin; Arrigo F G Cicero; Ada Dormi; Maddalena Veronesi; Eugenio Cosentino; Claudio Borghi
Prospective evaluation of the effect of statins on blood pressure control in hypertensive patients in clinical practice.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2010;20(7):512-8.
2010: Antonio Pirodda; Giovanni Carlo Modugno; Leonardo Manzari; Maria Chiara Raimondi; Cristina Brandolini; Gian Gaetano Ferri; Claudio Borghi
Meniere's disease and the use of proton pump inhibitors.
Swiss medical weekly 2010;140():w13104.
2010: Claudio Borghi; Arrigo F G Cicero
Rationale for the use of a fixed-dose combination in the management of hypertension: efficacy and tolerability of lercanidipine/enalapril.
Clinical drug investigation 2010;30(12):843-54.
2010: Arrigo F G Cicero; Giuseppe Derosa; Valentina Di Gregori; Marilisa Bove; Antonio V Gaddi; Claudio Borghi
Omega 3 polyunsaturated fatty acids supplementation and blood pressure levels in hypertriglyceridemic patients with untreated normal-high blood pressure and with or without metabolic syndrome: a retrospective study.
Clinical and experimental hypertension (New York, N.Y. : 1993) 2010;32(2):137-44.
2010: Arrigo F G Cicero; Ada Dormi; Sergio D'Addato; Antonio V Gaddi; Claudio Borghi
Long-term effect of a dietary education program on postmenopausal cardiovascular risk and metabolic syndrome: the Brisighella Heart Study.
Journal of women's health (2002) 2010;19(1):133-7.
2009: Claudio Borghi; Arrigo F G Cicero; Stefano Bacchelli; Daniela Degli Esposti; Ettore Ambrosioni
Serum cholesterol levels on admission and survival in patients with acute myocardial infarction treated with zofenopril: a post hoc analysis of the Survival of Myocardial Infarction Long-term Evaluation trial.
Fundamental & clinical pharmacology 2009;23(5):641-8.
2009: Arrigo F G Cicero; Maddalena Veronesi; Maria Grazia Prandin; Valentina Di Gregori; Ettore Ambrosioni; Claudio Borghi
Effects of AT1 receptor and beta1 receptor blocking on blood pressure, peripheral hemodynamic and lipid profile in statin-treated hypertensive hypercholesterolemic patients.
Fundamental & clinical pharmacology 2009;23(5):583-8.
2009: Antonio Pirodda; Cristina Brandolini; Maria Chiara Raimondi; Gian Gaetano Ferri; Claudio Borghi
Tinnitus as a warning for preventing vasovagal syncope.
Medical hypotheses 2009;73(3):370-1.
2009: Arrigo F G Cicero; Sibel Ertek; Claudio Borghi
Omega-3 polyunsaturated fatty acids: their potential role in blood pressure prevention and management.
Current vascular pharmacology 2009;7(3):330-7.
2009: Antonio Pirodda; Cristina Brandolini; Gian Gaetano Ferri; Giovanni Carlo Modugno; Daniela Degli Esposti; Claudio Borghi
Inner ear dysfunction of uncertain origin: a multidisciplinary approach could give something more.
Medical hypotheses 2009;72(2):188-9.
2009: Arrigo Francesco Giuseppe Cicero; Giuseppe Derosa; Angela D'angelo; Marilisa Bove; Antonio Vittorino Gaddi; Claudio Borghi
Gender-specific haemodynamic and metabolic effects of a sequential training programme on overweight-obese hypertensives.
Blood pressure 2009;18(3):111-6.
2009: Antonio Pirodda; Cristina Brandolini; Gian Gaetano Ferri; Maria Chiara Raimondi; Giovanni Carlo Modugno; Daniela Degli Esposti; Claudio Borghi
Possible influence on heart rate on tinnitus.
Medical hypotheses 2009;72(1):45-6.
2008: Ettore Ambrosioni; Arrigo F G Cicero; Alessandro Filippi; Damiano Parretti; Elena Peruzzi; Alessandro Rossi; Claudio Borghi
Global cardiovascular disease risk management in italian patients with metabolic syndrome in the clinical practice setting.
High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension 2008;15(2):37-45.
2008: Claudio Borghi; Arrigo F G Cicero; Ettore Ambrosioni
Effects of early treatment with zofenopril in patients with myocardial infarction and metabolic syndrome: the SMILE Study.
Vascular health and risk management 2008;4(3):665-71.
2008: Antonio Pirodda; Daniela Degli Esposti; Cristina Brandolini; Giovanni Carlo Modugno; Eugenio Cosentino; Claudio Borghi
Could echocardiography yield a cardiovascular profile of the tinnitus prone subject?
Medical hypotheses 2008;70(2):252-4.
2007: Maria Grazia Prandin; Arrigo F G Cicero; Maddalena Veronesi; Eugenio Cosentino; Ada Dormi; Enrico Strocchi; Claudio Borghi
Persistence on treatment and blood pressure control with different first-line antihypertensive treatments: a prospective evaluation.
Clinical and experimental hypertension (New York, N.Y. : 1993) 2007;29(8):553-62.
2007: Claudio Borghi; Maddalena Veronesi; Eugenio Cosentino; Arrigo F G Cicero; Frederick Kuria; Ada Dormi; Ettore Ambrosioni
Interaction between serum cholesterol levels and the renin-angiotensin system on the new onset of arterial hypertension in subjects with high-normal blood pressure.
Journal of hypertension 2007;25(10):2051-7.
2007: Claudio Borghi; Maddalena Veronesi; Ada Dormi; Maria Grazia Prandin; Eugenio Cosentino; Enrico Strocchi
Persistence of treatment and blood pressure control in elderly hypertensive patients treated with different classes of antihypertensive drugs.
The American journal of geriatric cardiology 2007;16(5):280-6.
2007: Arrigo F G Cicero; Giuseppe Derosa; Marco Manca; Marilisa Bove; Claudio Borghi; Antonio Gaddi
Different effect of psyllium and guar dietary supplementation on blood pressure control in hypertensive overweight patients: a six-month, randomized clinical trial.
Clinical and experimental hypertension (New York, N.Y. : 1993) 2007;29(6):383-94.
2007: Arrigo F G Cicero; Giuseppe Derosa; Marco Manca; Marilisa Bove; Claudio Borghi; Antonio Gaddi
Vascular remodeling and prothrombotic markers in subjects affected by familial combined hyperlipidemia and/or metabolic syndrome in primary prevention for cardiovascular disease.
Endothelium : journal of endothelial cell research 2007;14(4-5):193-8.
2007: Arrigo F G Cicero; Marco Manca; Marilisa Bove; Ada Dormi; Claudio Borghi; Antonio Gaddi
Detection of familial combined hyperlipoproteinaemia patients in the Brisighella Heart Study historical cohort: an epidemiological approach.
Journal of inherited metabolic disease 2007;30(2):268.
2007: Claudio Borghi; Ettore Ambrosioni
Effects of zofenopril on myocardial ischemia in post-myocardial infarction patients with preserved left ventricular function: the Survival of Myocardial Infarction Long-term Evaluation (SMILE)-ISCHEMIA study.
American heart journal 2007;153(3):445.e7-14.
2007: Alessandra Villani; Gabriella Malfatto; Francesco Della Rosa; Giovanna Branzi; Simona Boarin; Claudio Borghi; Eugenio Cosentino; Massimo Gualerzi; Paolo Coruzzi; Enrico Molinari; Angelo Compare; Maurizio Cassi; Stefano Collatina; Gianfranco Parati
[Disease management for heart failure patients: role of wireless technologies for telemedicine. The ICAROS project].
Giornale italiano di cardiologia (2006) 2007;8(2):107-14.
2007: Maddalena Veronesi; Arrigo F G Cicero; Maria Grazia Prandin; Ada Dormi; Eugenio Cosentino; Enrico Strocchi; Claudio Borghi
A prospective evaluation of persistence on antihypertensive treatment with different antihypertensive drugs in clinical practice.
Vascular health and risk management 2007;3(6):999-1005.
2006: Claudio Borghi; Stefano Bacchelli; Daniela Degli Esposti; Ettore Ambrosioni
Effects of early angiotensin-converting enzyme inhibition in patients with non-ST-elevation acute anterior myocardial infarction.
American heart journal 2006;152(3):470-7.
2006: Claudio Borghi; Arrigo F G Cicero
Omega-3 polyunsaturated fatty acids: Their potential role in blood pressure prevention and management.
Heart international 2006;2(2):98.
2006: Claudio Borghi; Arrigo F G Cicero
Fixed combination of zofenopril plus hydrochlorothiazide in the management of hypertension: a review of available data.
Vascular health and risk management 2006;2(4):341-9.
2006: Claudio Borghi
Compliance with therapy in hypertensive patients.
Internal and emergency medicine 2006;1(3):175-6.
2006: Claudio Borghi; Giovanni Carlo Modugno; Cristina Brandolini; Antonio Pirodda
Is tinnitus useful in early detection of incoming heart decompensation?
Medical hypotheses 2006;67(3):437-9.
2006: Claudio Borghi; Giovanni Carlo Modugno; Cristina Brandolini; Antonio Pirodda
Is there a role for atrial peptides in the labyrinthine "disease"?
Medical hypotheses 2006;66(6):1188-90.
2005: Claudio Borghi; Eugenio Cosentino; Davide De Sanctis
[Angiotensin-converting enzyme inhibition and cardiovascular prevention: more than twenty years of clinical success].
Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology 2005;6(12):769-79.
2005: Claudio Borghi
Lercanidipine in hypertension.
Vascular health and risk management 2005;1(3):173-82.
2004: D Caruso; Maria D'Avino; C Acampora; L Romano; Bevilacqua Nazario; G Caruso; Daniela Degli Esposti; Claudio Borghi
Effects of losartan and chlorthalidone on blood pressure and renal vascular resistance index in non-diabetic patients with essential hypertension and normal renal function.
Journal of cardiovascular pharmacology 2004;44(5):520-4.
2004: Claudio Borghi; Stefano Bacchelli; Daniela Degli Esposti; Ettore Ambrosioni
A review of the angiotensin-converting enzyme inhibitor, zofenopril, in the treatment of cardiovascular diseases.
Expert opinion on pharmacotherapy 2004;5(9):1965-77.
2004: Claudio Borghi; Ada Dormi; Sergio D'Addato; Antonio Gaddi; Ettore Ambrosioni
Trends in blood pressure control and antihypertensive treatment in clinical practice: the Brisighella Heart Study.
Journal of hypertension 2004;22(9):1707-16.
2004: Claudio Borghi; Ada Dormi; Maddalena Veronesi; Zina Sangiorgi; Antonio Gaddi
Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study.
American heart journal 2004;148(2):285-92.
2004: Claudio Borghi; Maddalena Veronesi; Stefano Bacchelli; Daniela Degli Esposti; Eugenio Cosentino; Ettore Ambrosioni
Serum cholesterol levels, blood pressure response to stress and incidence of stable hypertension in young subjects with high normal blood pressure.
Journal of hypertension 2004;22(2):265-72.
2003: Claudio Borghi; Maddalena Veronesi
[Hypercholesterolemia as cardiovascular risk in hypertensive patients. Therapeutic implications: efficiency of statins].
Recenti progressi in medicina 2003;94(10):421-6.
2003: Claudio Borghi; Stefano Bacchelli; Daniela Degli Esposti; Ettore Ambrosioni
Effects of the early ACE inhibition in diabetic nonthrombolyzed patients with anterior acute myocardial infarction.
Diabetes care 2003;26(6):1862-8.
2003: Claudio Borghi; Maria Grazia Prandin; Ada Dormi; Ettore Ambrosioni
Improved tolerability of the dihydropyridine calcium-channel antagonist lercanidipine: the lercanidipine challenge trial.
Blood pressure. Supplement 2003;1():14-21.
2003: Claudio Borghi; Ada Dormi; Gilbert J L'Italien; Pablo Lapuerta; Stanley S Franklin; Stefano Collatina; Antonio Gaddi
The relationship between systolic blood pressure and cardiovascular risk--results of the Brisighella Heart Study.
Journal of clinical hypertension (Greenwich, Conn.) 2003;5(1):47-52.
2003: Claudio Borghi; Ettore Ambrosioni
Double-blind comparison between zofenopril and lisinopril in patients with acute myocardial infarction: results of the Survival of Myocardial Infarction Long-term Evaluation-2 (SMILE-2) study.
American heart journal 2003;145(1):80-7.
2002: Claudio Borghi; Ada Dormi; Ettore Ambrosioni; Antonio Gaddi
Relative role of systolic, diastolic and pulse pressure as risk factors for cardiovascular events in the Brisighella Heart Study.
Journal of hypertension 2002;20(9):1737-42.
2002: Claudio Borghi
Interactions between hypercholesterolemia and hypertension: implications for therapy.
Current opinion in nephrology and hypertension 2002;11(5):489-96.
2002: Claudio Borghi; Ada Dormi; Maddalena Veronesi; Vincenzo Immordino; Ettore Ambrosioni
Use of lipid-lowering drugs and blood pressure control in patients with arterial hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2002;4(4):277-85.
2002: Giovanni Cremonesi; L Cavalieri; I Cikes; J Dobovisek; Stefano Bacchelli; Daniela Degli Esposti; francesco vittorio costa; Claudio Borghi; Ettore Ambrosioni
Fixed combinations of delapril plus indapamide vs fosinopril plus hydrochlorothiazide in mild to moderate essential hypertension.
Advances in therapy 2002;19(3):129-37.
2002: Claudio Borghi; Daniela Degli Esposti; Alberto Cassani; Vincenzo Immordino; Luciano Bovicelli; Ettore Ambrosioni
The treatment of hypertension in pregnancy.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 2002;20(2):S52-6.
2002: Claudio Borghi; Giovanni Carlo Modugno; Antonio Pirodda
Possible role of HMG-CoA reductase inhibitors for the treatment of sudden sensorineural hearing loss (SSHL).
Medical hypotheses 2002;58(5):399-402.
2001: Ettore Ambrosioni; Stefano Bacchelli; Daniela Degli Esposti; Claudio Borghi
Beta-blockade in hypertension and congestive heart failure.
Journal of cardiovascular pharmacology 2001;38 Suppl 3():S25-31.
2001: Antonio Pirodda; Gian Gaetano Ferri; Giovanni Carlo Modugno; Claudio Borghi
Systemic hypotension and the development of acute sensorineural hearing loss in young healthy subjects.
Archives of otolaryngology--head & neck surgery 2001;127(9):1049-52.
2001: Claudio Borghi; Maddalena Veronesi; Maria Grazia Prandin; Ada Dormi; Ettore Ambrosioni
Statins and blood pressure regulation.
Current hypertension reports 2001;3(4):281-8.
2001: Ettore Ambrosioni; Stefano Bacchelli; Daniela Degli Esposti; Claudio Borghi
Anti-ischemic effects of angiotensin-converting enzyme inhibitors: a future therapeutic perspective.
Journal of cardiovascular pharmacology 2001;37 Suppl 1():S3-9.
2000: Claudio Borghi; Daniela Degli Esposti; Vincenzo Immordino; A Cassani; Stefano Boschi; Luciano Bovicelli; Ettore Ambrosioni
Relationship of systemic hemodynamics, left ventricular structure and function, and plasma natriuretic peptide concentrations during pregnancy complicated by preeclampsia.
American journal of obstetrics and gynecology 2000;183(1):140-7.
2000: Claudio Borghi; Maria Grazia Prandin; francesco vittorio costa; Stefano Bacchelli; Daniela Degli Esposti; Ettore Ambrosioni
Use of statins and blood pressure control in treated hypertensive patients with hypercholesterolemia.
Journal of cardiovascular pharmacology 2000;35(4):549-55.
1999: Ettore Ambrosioni; Claudio Borghi
[Integrated approach to heart failure: a teaching and medical update model].
Cardiologia (Rome, Italy) 1999;44 Suppl 1(Pt 1):283-8.
1999: Claudio Borghi; Daniela Degli Esposti; Eugenio Cosentino
[Epidemiologic and socioeconomic impact of heart failure].
Cardiologia (Rome, Italy) 1999;44 Suppl 1(Pt 1):129-32.
1999: Claudio Borghi; Stefano Bacchelli
[Pharmacologic treatment in elderly patients with heart failure. Which precautions?].
Cardiologia (Rome, Italy) 1999;44 Suppl 1(Pt 2):815-9.
1999: Claudio Borghi; Stefano Bacchelli; Daniela Degli Esposti; A Bignamini; B Magnani; Ettore Ambrosioni
Effects of the administration of an angiotensin-converting enzyme inhibitor during the acute phase of myocardial infarction in patients with arterial hypertension. SMILE Study Investigators. Survival of Myocardial Infarction Long-term Evaluation.
American journal of hypertension 1999;12(7):665-72.
1998: Claudio Borghi; P Marino; P Zardini; B Magnani; Stefano Collatina; Ettore Ambrosioni
Short- and long-term effects of early fosinopril administration in patients with acute anterior myocardial infarction undergoing intravenous thrombolysis: results from the Fosinopril in Acute Myocardial Infarction Study. FAMIS Working Party.
American heart journal 1998;136(2):213-25.
1998: Claudio Borghi; Ettore Ambrosioni
Evidence-based medicine and ACE inhibition.
Journal of cardiovascular pharmacology 1998;32 Suppl 2():S24-35.
1997: Claudio Borghi; P Marino; P Zardini; B Magnani; Stefano Collatina; Ettore Ambrosioni
Post acute myocardial infarction: the Fosinopril in Acute Myocardial Infarction Study (FAMIS).
American journal of hypertension 1997;10(10 Pt 2):247S-254S.
1996: Claudio Borghi; Ettore Ambrosioni; B Magnani
Effects of the early administration of zofenopril on onset and progression of congestive heart failure in patients with anterior wall acute myocardial infarction. The SMILE Study Investigators. Survival of Myocardial Infarction Long-term Evaluation.
The American journal of cardiology 1996;78(3):317-22.
1996: Claudio Borghi; francesco vittorio costa; Stefano Boschi; S Bacchelli; D degli Esposti; M Piccoli; Ettore Ambrosioni
Factors associated with the development of stable hypertension in young borderline hypertensives.
Journal of hypertension 1996;14(4):509-17.
1996: Claudio Borghi; Ettore Ambrosioni
Primary and secondary prevention of myocardial infarction.
Clinical and experimental hypertension (New York, N.Y. : 1993) 1996;18(3-4):547-58.
1996: Claudio Borghi; Stefano Boschi; francesco vittorio costa; S Bacchelli; D Degli Esposti; V Immordino; M Piccoli; F Ambrosioni
Low dose of ACE-inhibitor enhances sodium excretion in volume expanded patients with borderline hypertension.
Blood pressure 1996;5(2):105-12.
1995: Ettore Ambrosioni; Claudio Borghi; B Magnani
The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators.
The New England journal of medicine 1995;332(2):80-5.
1994: Ettore Ambrosioni; Claudio Borghi; B Magnani
Survival of myocardial infarction long-term evaluation (SMILE) study: rationale, design, organization, and outcome definitions.
Controlled clinical trials 1994;15(3):201-10.
1993: Claudio Borghi; S Bacchelli; D Degli Esposti; Ettore Ambrosioni
Early and late angiotensin-converting enzyme inhibition in acute myocardial infarction.
The American journal of cardiology 1993;72(19):169G-174G.
1993: Claudio Borghi; Stefano Boschi; francesco vittorio costa; S Bacchelli; D Degli Esposti; M Piccoli; Ettore Ambrosioni
Effects of pharmacological modulation of the renin-angiotensin-aldosterone system on salt sensitivity in patients with borderline hypertension.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1993;11(5):S248-9.
1993: Claudio Borghi; Stefano Boschi; francesco vittorio costa; Ettore Ambrosioni
Atrial natriuretic factor response to acute volume expansion in borderline hypertension. Role of ACE-inhibition and changes in peripheral venous tone.
Clinical and experimental hypertension (New York, N.Y. : 1993) 1993;15(2):339-54.
1993: Ettore Ambrosioni; S Bacchelli; D Degli Esposti; Claudio Borghi
Ace-inhibitors and experimental atherosclerosis.
Clinical and experimental hypertension (New York, N.Y. : 1993) 1993;15 Suppl 1():157-72.
1993: Claudio Borghi; Stefano Boschi; Ettore Ambrosioni; G Melandri; A Branzi; B Magnani
Evidence of a partial escape of renin-angiotensin-aldosterone blockade in patients with acute myocardial infarction treated with ACE inhibitors.
Journal of clinical pharmacology 1993;33(1):40-5.
1992: Ettore Ambrosioni; S Bacchelli; D Degli Esposti; Claudio Borghi
ACE-inhibitors and atherosclerosis.
European journal of epidemiology 1992;8 Suppl 1():129-33.
1991: Claudio Borghi; Stefano Boschi; francesco vittorio costa; Ettore Ambrosioni
Determinants of acute salt sensitivity in hypertension-prone men.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991;9(6):S318-9.
1991: Ettore Ambrosioni; Claudio Borghi; B Magnani
Early treatment of acute myocardial infarction with angiotensin-converting enzyme inhibition: safety considerations. SMILE pilot study working party.
The American journal of cardiology 1991;68(14):101D-110D.
1991: Claudio Borghi; Stefano Boschi; francesco vittorio costa; Ettore Ambrosioni
Atrial natriuretic factor modulates the plasma levels of a Na+/K+ATPase inhibitor in volume expanded borderline hypertensives.
American journal of hypertension 1991;4(7 Pt 1):618-22.
1990: Claudio Borghi; Stefano Boschi; francesco vittorio costa; Ettore Ambrosioni
Pattern of peripheral venous response to volume expansion in borderline systemic hypertension.
The American journal of cardiology 1990;66(5):597-602.
1990: francesco vittorio costa; Claudio Borghi; Stefano Boschi; A Mussi; Ettore Ambrosioni
Alarm reaction and serum K+ in hypertensive patients.
American journal of hypertension 1990;3(8 Pt 1):638-40.
1990: Stefano Boschi; Claudio Borghi; A Munarini; francesco vittorio costa; Z R Lu; D deVries; Ettore Ambrosioni
Purification of a Na+/K+ ATPase inhibitor from borderline hypertensives' plasma.
Biochemical and biophysical research communications 1990;169(2):360-8.
1990: francesco vittorio costa; Claudio Borghi; Stefano Boschi; A Mussi; Ettore Ambrosioni
Hemodynamic and humoral effects of chronic antihypertensive treatment with fenquizone: importance of aldosterone response.
Journal of clinical pharmacology 1990;30(3):254-61.
1990: Claudio Borghi; Stefano Boschi; A Munarini; A Mussi; francesco vittorio costa; Ettore Ambrosioni
Short-term plasma renin activity suppression by saline and release of a plasma endogenous Na/K ATPase inhibitor in essential hypertension.
American journal of hypertension 1990;3(2):98-104.
1989: Claudio Borghi; Stefano Boschi; francesco vittorio costa; Ettore Ambrosioni
Changes in peripheral venous distensibility and blood pressure modifications in borderline hypertension: evidence against a primary role for the renin-angiotensin-aldosterone system.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1989;7(6):S80-1.
1989: Claudio Borghi; C Magelli; Stefano Boschi; francesco vittorio costa; M Capelli; E Varani; B Magnani; Ettore Ambrosioni
Peripheral hemodynamic and humoral effects of oral zofenopril calcium (SQ. 26,991) in patients with congestive heart failure.
Journal of clinical pharmacology 1989;29(12):1077-82.
1989: Ettore Ambrosioni; Claudio Borghi
Calcium channel antagonists in hypertension.
American journal of hypertension 1989;2(2 Pt 2):90S-93S.
1988: Claudio Borghi; francesco vittorio costa; Stefano Boschi; Ettore Ambrosioni
Impaired vasodilator capacity and exaggerated pressor response to isometric exercise in subjects with family history of hypertension.
American journal of hypertension 1988;1(3 Pt 3):106S-109S.
1988: francesco vittorio costa; Claudio Borghi; A Mussi; Ettore Ambrosioni
Use of captopril to reduce serum lipids in hypertensive patients with hyperlipidemia.
American journal of hypertension 1988;1(3 Pt 3):221S-223S.
1988: Claudio Borghi; Stefano Boschi; francesco vittorio costa; A Munarini; A Mussi; Ettore Ambrosioni
Importance of plasma renin activity suppression and venous distensibility on pressor and natriuretic responses to intravenous salt load in borderline hypertension.
American journal of hypertension 1988;1(3 Pt 1):294-7.
1988: Stefano Boschi; A Munarini; Claudio Borghi; E Strocchi; francesco vittorio costa; A Mussi; A Ettore
Characterization of a Na+/K+-ATPase inhibitor from human plasma: preliminary data.
American journal of hypertension 1988;1(3 Pt 3):56S-59S.
1988: francesco vittorio costa; Claudio Borghi; A Mussi; Ettore Ambrosioni
Hypolipidemic effects of long-term antihypertensive treatment with captopril. A prospective study.
The American journal of medicine 1988;84(3A):159-61.
1985: Ettore Ambrosioni; francesco vittorio costa; Claudio Borghi; A Mussi; Stefano Boschi
Modifications of intra- and extracellular sodium and potassium. A possible mechanism for the antihypertensive action of captopril and hydrochlorothiazide.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1985;3(3):S69-71.